Latest filing published 03 Jan 2011 for Acura Pharmaceuticals, INC, €189.
Insider track record
No signal scores available.
William Sumner: trading record in brief
William Sumner discloses dealings in Acura Pharmaceuticals, Inc to SEC (Form 4). Between 11 February 2006 and 1 January 2011, the trades on record add up to 3 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 3 January 2011 with a share grant (€189) in Acura Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to William Sumner
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 76 shares@ US$3.31Common StiockSEC:0001209191-11-000254:0
- 200,000 shares@ US$0.36Common StockSEC:0001209191-07-060752:0
- 1,000,000 sharesCommon StockSEC:0001144204-06-005746:0
3 of 3 declarations
